BGLC VS AFIB Stock Comparison
Performance
BGLC10/100
10/100
BGLC returned -97.12% in the last 12 months. Based on SPY's performance of -13.73%, its performance is below average giving it a score of 10 of 100.
AFIB10/100
10/100
AFIB returned -74.93% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.
Profit
BGLC33/100
33/100
Out of the last 18 quarters, BGLC has had 6 profitable quarters and has increased their profits year over year on 4 of them.
AFIB13/100
13/100
Out of the last 19 quarters, AFIB has had 2 profitable quarters and has increased their profits year over year on 2 of them.
Volatility
BGLC56/100
56/100
BGLC has had a higher than average amount of volatility over the last 12 months giving it a score of 56 of 100.
AFIB30/100
30/100
AFIB has had a lower than average amount of volatility over the last 12 months giving it a score of 30 of 100.
Technicals
BGLC
"Technicals" not found for BGLC
AFIB14/100
14/100
AFIB receives a 14 of 100 based on 14 indicators. 2 are bullish, 12 are bearish.
Earnings
BGLC
"Earnings" not found for BGLC
AFIB10/100
10/100
AFIB has missed earnings 7 times in the last 20 quarters.
All score calculations are broken down here to help you make more informed investing decisions
BioNexus Gene Lab Corp Common stock Summary
Nasdaq / BGLC
Healthcare
Medical - Diagnostics & Research
BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.
Acutus Medical, Inc. Common Stock Summary
Nasdaq / AFIB
Healthcare
Medical - Devices
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Compare Similar Companies
Compare BGLC to other companies in the same or a similar industry.